11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Influence of hyperthermal regimes on experimental teratoma development in vitro

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Summary

          We screened for the impact of hyperthermal regimes varying in the cumulative equivalent minutes at 43°C (CEM43°C) and media composition on tumour development using an original teratoma in vitro model. Rat embryos (three germ layers) were microsurgically isolated and cultivated at the air‐liquid interface. During a two week period, ectodermal, mesodermal and endodermal derivatives developed within trilaminar teratomas. Controls were grown at 37°C. Overall growth was measured, and teratoma survival and differentiation were histologically assessed. Cell proliferation was stereologically quantified by the volume density of Proliferating Cell Nuclear Antigen. Hyperthermia of 42°C, applied for 15 minutes after plating (CEM43°C 3.75 minutes), diminished cell proliferation ( P ˂ .0001) and enhanced differentiation of both myotubes ( P ˂ .01) and cylindrical epithelium ( P ˂ .05). Hyperthermia of 43°C applied each day for 30 minutes during the first week (CEM43°C 210 minutes) impaired overall growth ( P ˂ .01) and diminished cell proliferation ( P ˂ .0001). Long‐term hyperthermia of 40.5°C applied for two weeks (CEM43°C 630 minutes) significantly impaired survival ( P ˂ .005). Long‐term hyperthermia of 40.5°C applied from the second day when differentiation of tissues begins (CEM43°C 585 minutes) impaired survival ( P ˂ .0001), overall growth ( P ˂ .01) and cartilage differentiation ( P ˂ .05). No teratomas survived extreme regimes: 43°C for 24 hours (CEM43°C 1440 minutes), hyperthermia in the scant serum‐free medium (CEM43°C 630 minutes) or treatment with an anti‐HSP70 antibody before long‐term hyperthermia 40.5°C from the second day (CEM43°C 585 minutes). This in vitro research provided novel insights into the impact of hyperthermia on the development of experimental teratomas from their undifferentiated sources and are thus of potential interest for future therapeutic strategies in corresponding in vivo models.

          Related collections

          Most cited references72

          • Record: found
          • Abstract: found
          • Article: not found

          Thresholds for thermal damage to normal tissues: an update.

          The purpose of this review is to summarise a literature survey on thermal thresholds for tissue damage. This review covers published literature for the consecutive years from 2002-2009. The first review on this subject was published in 2003. It included an extensive discussion of how to use thermal dosimetric principles to normalise all time-temperature data histories to a common format. This review utilises those same principles to address sensitivity of a variety of tissues, but with particular emphasis on brain and testis. The review includes new data on tissues that were not included in the original review. Several important observations have come from this review. First, a large proportion of the papers examined for this review were discarded because time-temperature history at the site of thermal damage assessment was not recorded. It is strongly recommended that future research on this subject include such data. Second, very little data is available examining chronic consequences of thermal exposure. On a related point, the time of assessment of damage after exposure is critically important for assessing whether damage is transient or permanent. Additionally, virtually no data are available for repeated thermal exposures which may occur in certain recreational or occupational activities. For purposes of regulatory guidelines, both acute and lasting effects of thermal damage should be considered.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Hyperthermia: a potent enhancer of radiotherapy.

            Hyperthermia is generally regarded as an experimental treatment with no realistic future in clinical cancer therapy. This is totally wrong. Although the role of hyperthermia alone as a cancer treatment may be limited, there is extensive pre-clinical data showing that in combination with radiation it is one of the most effective radiation sensitisers known. Moreover, there are a number of large randomised clinical trials in a variety of tumour types that clearly show the potential of hyperthermia to significantly improve both local tumour control and survival after radiation therapy, without a significant increase in side-effects. Here we review the pre-clinical rationale for combining hyperthermia with radiation, and summarise the clinical data showing its efficacy.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Therapeutic strategies targeting cancer stem cells

              Cancer stem cells (CSCs) are undifferentiated cancer cells with a high tumorigenic activity, the ability to undergo self‐renewal, and a multilineage differentiation potential. Cancer stem cells are responsible for the development of tumor cell heterogeneity, a key feature for resistance to anticancer treatments including conventional chemotherapy, radiation therapy, and molecularly targeted therapy. Furthermore, minimal residual disease, the major cause of cancer recurrence and metastasis, is enriched in CSCs. Cancer stem cells also possess the property of “robustness”, which encompasses several characteristics including a slow cell cycle, the ability to detoxify or mediate the efflux of cytotoxic agents, resistance to oxidative stress, and a rapid response to DNA damage, all of which contribute to the development of therapeutic resistance. The identification of mechanisms underlying such characteristics and the development of novel approaches to target them will be required for the therapeutic elimination of CSCs and the complete eradication of tumors. In this review, we focus on two prospective therapeutic approaches that target CSCs with the aim of disrupting their quiescence or redox defense capability.
                Bookmark

                Author and article information

                Contributors
                ana.katusic@mef.hr
                Journal
                Int J Exp Pathol
                Int J Exp Pathol
                10.1111/(ISSN)1365-2613
                IEP
                International Journal of Experimental Pathology
                John Wiley and Sons Inc. (Hoboken )
                0959-9673
                1365-2613
                01 August 2018
                June 2018
                01 August 2018
                : 99
                : 3 ( doiID: 10.1111/iep.2018.99.issue-3 )
                : 131-144
                Affiliations
                [ 1 ] Department of Medical Biology University of Zagreb School of Medicine Zagreb Croatia
                [ 2 ] Centre of Excellence in Reproductive and Regenerative Medicine University of Zagreb School of Medicine Zagreb Croatia
                [ 3 ] Department of Histology and Embryology University of Zagreb School of Medicine Zagreb Croatia
                Author notes
                [*] [* ] Correspondence

                Ana Katusic Bojanac, Department of Medical Biology, University of Zagreb School of Medicine, Zagreb, Croatia and Centre of Excellence in Reproductive and Regenerative Medicine, University of Zagreb School of Medicine, Zagreb, Croatia.

                Email: ana.katusic@ 123456mef.hr

                Author information
                http://orcid.org/0000-0002-9078-4966
                Article
                IEP12273
                10.1111/iep.12273
                6104434
                30066346
                686b97d2-1920-4135-bbe8-74791fe356bc
                © 2018 The Authors. International Journal of Experimental Pathology published by John Wiley & Sons Ltd on behalf of Company of the International Journal of Experimental Pathology (CIJEP).

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

                History
                : 23 February 2018
                : 15 May 2018
                Page count
                Figures: 6, Tables: 7, Pages: 14, Words: 10009
                Funding
                Funded by: EU Regional Development Fund
                Award ID: KK.01.1.1.01.0008
                Funded by: Croatian Ministry of Science and Education
                Award ID: 108‐1080399‐0335
                Funded by: University of Zagreb Supportive Grant
                Award ID: 1.2.1.17
                Award ID: 1101310
                Award ID: BM1.22
                Categories
                Original Article
                Original Articles
                Custom metadata
                2.0
                iep12273
                June 2018
                Converter:WILEY_ML3GV2_TO_NLMPMC version:version=5.4.4 mode:remove_FC converted:22.08.2018

                Pathology
                anti‐hsp,differentiation,embryo,growth,hyperthermia,teratoma
                Pathology
                anti‐hsp, differentiation, embryo, growth, hyperthermia, teratoma

                Comments

                Comment on this article